Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Grace Nguyen

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
International Journal of Molecular Sciences|May 28, 2022
Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo MiceRyan Kurtz, Andrew Libby, Bryce A Jones, et al.
Clinical and Translational Science|December 28, 2025
Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyNihal El Rouby, Christina L Aquilante, Salma A Bargal, et al.
JCO Precision Oncology|June 27, 2024
Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer CenterD Grace Nguyen, Sarah A Morris, Alicia Hamilton, et al.
Neuro-Oncology|June 10, 2024
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapyMin Hye Noh, Jin Muk Kang, Alexandra A Miller, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
International Journal of Molecular Sciences|May 28, 2022
Empagliflozin Treatment Attenuates Hepatic Steatosis by Promoting White Adipose Expansion in Obese TallyHo MiceRyan Kurtz, Andrew Libby, Bryce A Jones, et al.
Clinical and Translational Science|December 28, 2025
Global Investigation of Clinical Implementation Strategies for DPYD Testing to Guide Fluoropyrimidine TherapyNihal El Rouby, Christina L Aquilante, Salma A Bargal, et al.
JCO Precision Oncology|June 27, 2024
Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (<i>DPYD</i>) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer CenterD Grace Nguyen, Sarah A Morris, Alicia Hamilton, et al.
Neuro-Oncology|June 10, 2024
Targeting IGF2 to reprogram the tumor microenvironment for enhanced viro-immunotherapyMin Hye Noh, Jin Muk Kang, Alexandra A Miller, et al.
Pageof 3